Cost of treatment and QALYs lost due to genital warts: data for the economic evaluation of HPV vaccines in the United Kingdom


Woodhall, SC; Jit, M; Cai, C; Ramsey, T; Zia, S; Crouch, S; Birks, Y; Newton, R; Edmunds, WJ; Lacey, CJ; (2009) Cost of treatment and QALYs lost due to genital warts: data for the economic evaluation of HPV vaccines in the United Kingdom. Sexually transmitted diseases, 36 (8). pp. 515-21. ISSN 0148-5717 DOI: 10.1097/OLQ.0b013e3181a74c2c

Full text not available from this repository.

Abstract

BACKGROUND: Data on the burden of genital warts in terms of treatment costs and detriment to quality of life (QoL) are required to assess cost-effectiveness of quadrivalent human papillomavirus vaccination. We investigated the cost of treatment and period of time for which QoL is affected to obtain estimates of quality-adjusted life year (QALY) loss associated with an episode of genital warts. METHODS: Adults diagnosed with genital warts attending the York sexually transmitted disease clinic during two 3-month periods in 2006 and 2007 were enrolled (n = 189). Data on cost of treatment and duration of episode of care were collected from a retrospective case note review. QALY loss was calculated by applying estimates of the duration of time for which QoL was affected to the previously reported detriment to QoL associated with genital warts. RESULTS: The average cost per episode of care was 286 US dollars (139 pound, 95% CI: 246-327 US dollars). Estimated loss of QALYs ranged from 0.0045 (95% CI: 0.0014-0.0078) to 0.023 (95% CI: 0.0072-0.039). CONCLUSIONS: Genital warts present a significant burden both to individuals and to the health service. Data on the burden of genital warts should be incorporated into economic evaluations of human papillomavirus vaccination strategies.

Item Type: Article
Keywords: Adolescent, Adult, Condylomata Acuminata/*economics/epidemiology/prevention & control, Costs and Cost Analysis, Female, Great Britain/epidemiology, Health Care Costs, Humans, Male, Papillomavirus Infections/*economics/epidemiology/prevention & control, Papillomavirus Vaccines/administration & dosage/*economics, Quality of Life, *Quality-Adjusted Life Years, Time Factors, Young Adult, Adolescent, Adult, Condylomata Acuminata, economics, epidemiology, prevention & control, Costs and Cost Analysis, Female, Great Britain, epidemiology, Health Care Costs, Humans, Male, Papillomavirus Infections, economics, epidemiology, prevention & control, Papillomavirus Vaccines, administration & dosage, economics, Quality of Life, Quality-Adjusted Life Years, Time Factors, Young Adult
Faculty and Department: Faculty of Epidemiology and Population Health > Dept of Infectious Disease Epidemiology
PubMed ID: 19543143
Web of Science ID: 268425900010
URI: http://researchonline.lshtm.ac.uk/id/eprint/2979

Statistics


Download activity - last 12 months
Downloads since deposit
0Downloads
319Hits
Accesses by country - last 12 months
Accesses by referrer - last 12 months
Impact and interest
Additional statistics for this record are available via IRStats2

Actions (login required)

Edit Item Edit Item